• Thomas Maier cut his total voting rights in Pentixapharm Holding to 2.91% from 3.86%.
• The holding reflects 1,042,089 voting rights held indirectly via Glycotope.
• No voting rights were reported through instruments.
• The threshold was crossed on July 30, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pentixapharm Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: PVR_2377232_en) on August 04, 2026, and is solely responsible for the information contained therein.